The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells.

angiogenesis cancer biomarker drug resistance metastasis platelet platelet-derived growth factor

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
19 Feb 2019
Historique:
received: 06 01 2019
revised: 29 01 2019
accepted: 15 02 2019
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 23 2 2019
Statut: epublish

Résumé

Besides the critical functions in hemostasis, thrombosis and the wounding process, platelets have been increasingly identified as active players in various processes in tumorigenesis, including angiogenesis and metastasis. Once activated, platelets can release bioactive contents such as lipids, microRNAs, and growth factors into the bloodstream, subsequently enhancing the platelet⁻cancer interaction and stimulating cancer metastasis and angiogenesis. The mechanisms of treatment failure of chemotherapeutic drugs have been investigated to be associated with platelets. Therefore, understanding how platelets contribute to the tumor microenvironment may potentially identify strategies to suppress cancer angiogenesis, metastasis, and drug resistance. Herein, we present a review of recent investigations on the role of platelets in the tumor-microenvironment including angiogenesis, and metastasis, as well as targeting platelets for cancer treatment, especially in drug resistance.

Identifiants

pubmed: 30791448
pii: cancers11020240
doi: 10.3390/cancers11020240
pmc: PMC6406993
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2016M3A9B6903499

Références

Blood. 2001 Feb 1;97(3):638-44
pubmed: 11157479
Cancer Res. 2001 Jan 1;61(1):383-91
pubmed: 11196191
Mol Cell Biol. 2001 Oct;21(19):6387-94
pubmed: 11533228
Br J Cancer. 2003 Jun 2;88(11):1721-6
pubmed: 12771987
Drug Resist Updat. 2003 Jun;6(3):111-27
pubmed: 12860459
Haematologica. 2003 Oct;88(10):1117-22
pubmed: 14555307
Am J Pathol. 2004 Apr;164(4):1263-73
pubmed: 15039215
Leukemia. 2004 Jun;18(6):1078-84
pubmed: 15085157
Ann Med. 2004;36(4):273-7
pubmed: 15224653
Drug Metab Rev. 2005;37(1):253-78
pubmed: 15747503
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):855-60
pubmed: 16418262
Stem Cells. 2006 Nov;24(11):2420-7
pubmed: 17071858
Mol Cancer Res. 2007 Mar;5(3):203-20
pubmed: 17374728
J Cell Sci. 2007 May 15;120(Pt 10):1810-7
pubmed: 17502485
Cancer Res. 2007 May 15;67(10):4767-73
pubmed: 17510405
Clin Pharmacokinet. 2007;46(6):449-70
pubmed: 17518506
Trends Mol Med. 2008 Mar;14(3):109-19
pubmed: 18261959
Blood. 2009 Mar 19;113(12):2835-42
pubmed: 19036702
Int J Cancer. 2009 May 15;124(10):2303-11
pubmed: 19142964
J Exp Med. 2009 Aug 31;206(9):1913-27
pubmed: 19667060
Cancer Res. 2009 Oct 1;69(19):7775-83
pubmed: 19738039
Mol Endocrinol. 2010 Aug;24(8):1569-80
pubmed: 20610539
Tissue Eng Part A. 2011 May;17(9-10):1181-9
pubmed: 21142700
J Urol. 2011 Feb;185(2):693-700
pubmed: 21168861
Int J Oncol. 2012 Jan;40(1):109-18
pubmed: 21887461
Cancer Cell. 2011 Nov 15;20(5):576-90
pubmed: 22094253
Br J Pharmacol. 2012 Jun;166(3):938-49
pubmed: 22122360
Cancer Res. 2012 Jan 15;72(2):440-8
pubmed: 22127925
Blood. 2012 May 3;119(18):4283-90
pubmed: 22294729
Blood. 2012 Apr 12;119(15):3394-402
pubmed: 22337717
Br J Pharmacol. 2012 Oct;167(4):787-804
pubmed: 22506717
Haematologica. 2012 Sep;97(9):1444
pubmed: 22532521
Oncogene. 2013 May 30;32(22):2726-38
pubmed: 22797060
Cancer Discov. 2012 Dec;2(12):1150-65
pubmed: 22896036
Oncol Lett. 2013 Feb;5(2):675-680
pubmed: 23420392
Cell Biol Int. 2013 May;37(5):478-84
pubmed: 23584798
Blood. 2013 Jun 27;121(26):5192-202
pubmed: 23632889
Blood. 2014 Jan 2;123(1):101-12
pubmed: 24065244
Dis Markers. 2013;35(5):301-10
pubmed: 24167378
PLoS One. 2013 Nov 13;8(11):e80780
pubmed: 24236201
J Cell Physiol. 2014 Aug;229(8):1005-15
pubmed: 24374897
Drug Metab Dispos. 2014 Apr;42(4):726-34
pubmed: 24440960
PLoS One. 2014 Apr 30;9(4):e96402
pubmed: 24788652
Int J Cancer. 2015 Feb 1;136(3):688-98
pubmed: 24895203
Eur J Med Chem. 2014 Jul 23;82:139-51
pubmed: 24904961
Clin Exp Metastasis. 2014 Aug;31(6):697-704
pubmed: 24942131
J Endod. 2014 Nov;40(11):1810-4
pubmed: 25175848
Blood. 2014 Nov 13;124(20):3141-50
pubmed: 25277122
ScientificWorldJournal. 2014;2014:878209
pubmed: 25379550
Clin Cancer Res. 2015 Feb 1;21(3):602-10
pubmed: 25473001
J Endod. 2015 May;41(5):663-70
pubmed: 25687363
PLoS One. 2015 Feb 25;10(2):e0111532
pubmed: 25714433
BMC Cancer. 2015 Apr 15;15:290
pubmed: 25886038
Int J Biol Sci. 2015 Apr 29;11(6):679-87
pubmed: 25999791
J Thromb Haemost. 2015 Jun;13 Suppl 1:S40-6
pubmed: 26149049
Thromb Haemost. 2015 Nov 25;114(6):1310-21
pubmed: 26178021
Tumour Biol. 2016 Feb;37(2):1889-99
pubmed: 26323258
Cancer Biol Ther. 2015;16(11):1651-9
pubmed: 26418972
Biomaterials. 2016 Jan;76:52-65
pubmed: 26519648
Oncotarget. 2016 Jan 5;7(1):1066-75
pubmed: 26544515
Oncol Rep. 2016 Feb;35(2):1222
pubmed: 26718652
Cell Physiol Biochem. 2016;38(1):1-14
pubmed: 26741636
Thromb Res. 2016 Apr;140 Suppl 1:S27-36
pubmed: 27067975
Oncotarget. 2016 May 31;7(22):32462-77
pubmed: 27074574
Drug Resist Updat. 2016 Mar;25:26-37
pubmed: 27155374
Thromb Res. 2016 Apr;140 Suppl 1:S182
pubmed: 27161706
Growth Factors. 2016 Feb;34(1-2):64-71
pubmed: 27170215
Leuk Lymphoma. 2017 Jan;58(1):104-109
pubmed: 27267543
Oncol Rep. 2016 Aug;36(2):787-94
pubmed: 27349611
EJIFCC. 2012 Oct 12;23(3):87-97
pubmed: 27683421
Int J Oncol. 2016 Dec;49(6):2387-2398
pubmed: 27748800
Am J Physiol Cell Physiol. 2017 Feb 1;312(2):C176-C189
pubmed: 27903583
Oncotarget. 2017 Jan 10;8(2):2329-2341
pubmed: 27911876
Sci Rep. 2017 Feb 08;7:42186
pubmed: 28176852
J Clin Lab Anal. 2018 Jan;32(1):null
pubmed: 28238215
Int J Cancer. 2017 Jul 15;141(2):220-230
pubmed: 28240776
Clin Transl Oncol. 2017 Aug;19(8):989-996
pubmed: 28247194
J Cancer. 2017 Feb 25;8(5):761-773
pubmed: 28382138
Cell Physiol Biochem. 2017;41(6):2319-2332
pubmed: 28463834
Blood. 2017 Jun 22;129(25):3389-3391
pubmed: 28468795
Bioorg Med Chem. 2017 Jul 1;25(13):3396-3405
pubmed: 28478865
Blood. 2017 Aug 3;130(5):567-580
pubmed: 28500171
Sci Rep. 2017 Jun 14;7(1):3456
pubmed: 28615714
J Surg Res. 2017 Sep;217:113-122
pubmed: 28629815
Cancer Biol Ther. 2017 Aug 3;18(8):627-634
pubmed: 28718695
Sci Rep. 2017 Jul 21;7(1):6113
pubmed: 28733640
Cancers (Basel). 2017 Jul 22;9(7):null
pubmed: 28737696
Nat Commun. 2017 Aug 21;8(1):310
pubmed: 28827520
Phytomedicine. 2017 Oct 15;34:136-142
pubmed: 28899495
J BUON. 2017 Jul-Aug;22(4):1032-1037
pubmed: 28952224
Cancers (Basel). 2017 Oct 24;9(10):null
pubmed: 29064388
Platelets. 2018 Nov;29(7):723-728
pubmed: 29090588
Prostate. 2018 Jan;78(1):48-53
pubmed: 29094381
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1-8
pubmed: 29098884
Thorac Cancer. 2018 Jan;9(1):112-119
pubmed: 29105365
Mol Ther Oncolytics. 2017 Oct 24;8:1-13
pubmed: 29234727
J Clin Lab Anal. 2018 Jun;32(5):e22364
pubmed: 29251364
Onco Targets Ther. 2017 Dec 21;11:59-65
pubmed: 29317834
Clin Chim Acta. 2018 Apr;479:160-165
pubmed: 29325800
Oncotarget. 2017 Nov 6;8(67):110994-111011
pubmed: 29340032
Biomark Res. 2018 Jan 12;6:2
pubmed: 29344361
Cancer Lett. 2018 Apr 10;419:152-166
pubmed: 29414303
J Proteomics. 2018 Apr 15;177:65-74
pubmed: 29432918
J Thromb Haemost. 2018 Apr;16(4):791-801
pubmed: 29442415
Cancer Cell. 2018 Jun 11;33(6):965-983
pubmed: 29657130
Fam Pract. 2018 Dec 12;35(6):671-675
pubmed: 29659802
Sci Rep. 2018 Apr 16;8(1):6014
pubmed: 29662100
Cell Rep. 2018 Apr 17;23(3):808-822
pubmed: 29669286
Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2633-2643
pubmed: 29684582
Hepatology. 2018 Nov;68(5):1865-1878
pubmed: 29704239
Mol Ther Nucleic Acids. 2018 Jun 1;11:455-467
pubmed: 29858080
Haematologica. 2018 Sep;103(9):1557-1567
pubmed: 29880611
Braz Oral Res. 2018 Jun 11;32:e48
pubmed: 29898028
Curr Med Chem. 2018 Jul 26;:null
pubmed: 30047325
Oncol Lett. 2018 Jul;16(1):1123-1132
pubmed: 30061938
Sci Rep. 2018 Aug 7;8(1):11814
pubmed: 30087357
Cell Physiol Biochem. 2018;48(6):2456-2469
pubmed: 30121639
Mol Ther Nucleic Acids. 2018 Sep 7;12:817-828
pubmed: 30153566
Sci Rep. 2018 Sep 25;8(1):14365
pubmed: 30254326
Int J Mol Sci. 2018 Sep 26;19(10):null
pubmed: 30261608
Int J Mol Sci. 2018 Oct 22;19(10):null
pubmed: 30360388
Cancer Lett. 2019 Feb 1;442:320-332
pubmed: 30391782
PLoS One. 2018 Nov 14;13(11):e0207224
pubmed: 30427884
Med Sci Monit. 2018 Nov 30;24:8655-8668
pubmed: 30498189
Cancers (Basel). 2018 Dec 04;10(12):null
pubmed: 30518036
Gastrointest Tumors. 2018 Sep;5(1-2):32-37
pubmed: 30574479
Br J Pharmacol. 1998 Nov;125(6):1252-7
pubmed: 9863654

Auteurs

Phung Thanh Huong (PT)

Department of Biochemistry, Hanoi University of Pharmacy, Hanoi 10000, Vietnam. huongpt@hup.edu.vn.

Lap Thi Nguyen (LT)

Department of Biochemistry, Hanoi University of Pharmacy, Hanoi 10000, Vietnam. lapnt29@gmail.com.

Xuan-Bac Nguyen (XB)

Department of Biochemistry, Hanoi University of Pharmacy, Hanoi 10000, Vietnam. bac.biochemistry.hup@gmail.com.

Sang Kook Lee (SK)

College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Korea. sklee61@snu.ac.kr.

Duc-Hiep Bach (DH)

College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Korea. dbach@mdanderson.org.

Classifications MeSH